Current Diagnostic and Treatment Approach of Clostridioides difficile Infection

Bella Yunita, Achmad Fauzi


C. difficile infection is related to wide spectrum of disease, from self-limiting diarrhea to fulminant disease that can cause toxic megacolon or pseudo-membrane colitis. Difficult approach to diagnose this disease is also problem. C. difficile infection is diagnosed when diarrhea occurred in high risk patient with positive result of GDH or NAAT test that was confirmed by positive result of toxin test. Nevertheless, there is limited choice of treatment in Indonesia. Thus, the main priority of C. difficile infection  in Indonesia is associated with its prevention, by implementing standard precaution and use of rational antimicrobial.


C. difficile; infection; colitis; diagnosis; diarrhea; treatment


Collins DA, Gasem MH, Habibie TH, et al. Prevalence and molecular epidemiology of Clostridium difficile infection in Indonesia. New Microbe and New Infect. 2017;18:34-7.

McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society of Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:e1-48.

Kelly CR, Fischer M, Allegretti JR, et al. ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021;116:1124-47.

Fu Y, Luo Y, Grinspan AM. Epidemiology of community-acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol. 2021;14:1-11.

Sandhu BK, McBride SM. Clostridioides difficile. Trends Microbiol. 2018;26:1049-50.

Guh AY, Kutty PK. In the clinic: Clostridioides difficile infection. Ann Intern Med. 2018;169:ITC49-64.

Liwang F, Sinto R. Pendekatan klinis terkini infeksi Clostridium difficile nosocomial. JPDI. 2021;8:104-9.

Smilings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrobe Chemother. 2014;69:881-91.

Bauer MP, Hensgens MP, Miller MA, et al. Renal failure and leukocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clin Infect Dis. 2012;55:S149-53.

van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021;27:S1-21.

Gupta A, Khanna S. Fecal microbiota transplantation. JAMA. 2017;318:1.

Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021;73: e1029-44.

Cho JM, Pardi DS, Khanna S. Update on treatment of Clostridioides difficile infection. Mayo Clin Proc. 2020;95:758-69.

Guery B, Galperine T, Barbut F. Clostridioides difficile: diagnosis and treatments. BMJ. 2019;366:l4609.

Full Text: PDF


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.